Your browser doesn't support javascript.
loading
Impaired cardiac and peripheral hemodynamic responses to inhaled ß2-agonist in cystic fibrosis.
Van Iterson, Erik H; Karpen, Stephen R; Baker, Sarah E; Wheatley, Courtney M; Morgan, Wayne J; Snyder, Eric M.
Afiliação
  • Van Iterson EH; School of Kinesiology, University of Minnesota, Cooke Hall, 1900 University Ave SE., Minneapolis, MN, 55455, USA. vanit001@umn.edu.
  • Karpen SR; Department of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. vanit001@umn.edu.
  • Baker SE; College of Pharmacy, University of Arizona, 1295 N Martin Ave, Tucson, AZ, 85721, USA. karpen@pharmacy.arizona.edu.
  • Wheatley CM; College of Pharmacy, University of Arizona, 1295 N Martin Ave, Tucson, AZ, 85721, USA. baker.sarah@mayo.edu.
  • Morgan WJ; Department of Anesthesiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. baker.sarah@mayo.edu.
  • Snyder EM; College of Pharmacy, University of Arizona, 1295 N Martin Ave, Tucson, AZ, 85721, USA. wheatley.courtney@mayo.edu.
Respir Res ; 16: 103, 2015 Sep 05.
Article em En | MEDLINE | ID: mdl-26341519
ABSTRACT

BACKGROUND:

Pulmonary system dysfunction is a hallmark of cystic fibrosis (CF) disease. In addition to impaired cystic fibrosis transmembrane conductance regulator protein, dysfunctional ß2-adrenergic receptors (ß2AR) contribute to low airway function in CF. Recent observations suggest CF may also be associated with impaired cardiac function that is demonstrated by attenuated cardiac output (Q), stroke volume (SV), and cardiac power (CP) at both rest and during exercise. However, ß2AR regulation of cardiac and peripheral vascular tissue, in-vivo, is unknown in CF. We have previously demonstrated that the administration of an inhaled ß-agonist increases SV and Q while also decreasing SVR in healthy individuals. Therefore, we aimed to assess cardiac and peripheral hemodynamic responses to the selective ß2AR agonist albuterol in individuals with CF.

METHODS:

18 CF and 30 control (CTL) subjects participated (ages 22 ± 2 versus 27 ± 2 and BSA = 1.7 ± 0.1 versus 1.8 ± 0.0 m(2), both p < 0.05). We assessed the following at baseline and at 30- and 60-minutes following nebulized albuterol (2.5mg diluted in 3.0mL of normal saline) inhalation 12-lead ECG for HR, manual sphygmomanometry for systolic and diastolic blood pressure (SBP and DBP, respectively), acetylene rebreathe for Q and SV. We calculated MAP = DBP + 1/3(SBP-DBP); systemic vascular resistance (SVR) = (MAP/Q)•80; CP = Q•MAP; stroke work (SW) = SV•MAP; reserve (%change baseline to 30- or 60-minutes). Hemodynamics were indexed to BSA (QI, SVI, SWI, CPI, SVRI).

RESULTS:

At baseline, CF demonstrated lower SV, SVI, SW, and SWI but higher HR than CTL (p < 0.05); other measures did not differ. At 30-minutes, CF demonstrated higher HR and SVRI, but lower Q, SV, SVI, CP, CPI, SW, and SWI versus CTL (p < 0.05). At 60-minutes, CF demonstrated higher HR, SVR, and SVRI, whereas all cardiac hemodynamics were lower than CTL (p < 0.05). Reserves of CP, SW, and SVR were lower in CF versus CTL at both 30 and 60-minutes (p < 0.05).

CONCLUSIONS:

Cardiac and peripheral hemodynamic responsiveness to acute ß2AR stimulation via albuterol is attenuated in individuals with CF, suggesting ß2AR located in cardiac and peripheral vascular tissue may be dysfunctional in this population.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Receptores Adrenérgicos beta 2 / Fibrose Cística / Albuterol / Agonistas de Receptores Adrenérgicos beta 2 / Hemodinâmica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Receptores Adrenérgicos beta 2 / Fibrose Cística / Albuterol / Agonistas de Receptores Adrenérgicos beta 2 / Hemodinâmica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article